Inventor · disambiguated record
Jiayi Xu
Also filed as: XU JIAYI
19 granted patents·5 pending applications·77 citations·filing 2002–2024
90Inventor score
Files withMERCK SHARP & DOHME9AJAX THERAPEUTICS INC8JANSSEN PHARMACEUTICA NV3FAXIAN THERAPEUTICS LLC1JAIN NARESHKUMAR F1
Top patents by PatentIndex Score
24 records- 0192US11691963B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 4, 2023·5 cites·30 claims
- 0290US7329654B2Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Feb 12, 2008·51 cites·26 claims
- 0386US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0484US12043632B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2021·Granted Jul 23, 2024·1 cites·35 claims
- 0580US7105679B2Heteroatom containing tetracyclic derivatives as selective estrogen receptor modulatorsKANOJIA RAMESH M·Filed 2003·Granted Sep 12, 2006·14 cites·5 claims
- 0676US9527838B22-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatmentMERCK SHARP & DOHME·Filed 2013·Granted Dec 27, 2016·1 cites·13 claims
- 0773US2024254125A16-heteroaryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0871US11970494B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2022·Granted Apr 30, 2024·0 cites·30 claims
- 0970US12275717B26-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Granted Apr 15, 2025·0 cites·29 claims
- 1069US10344039B2Macrocyclic spirocarbamate derivatives as factor XIa inhibitors, pharmaceutically acceptable compositions and their useMERCK SHARP & DOHME·Filed 2016·Granted Jul 9, 2019·1 cites·17 claims
- 1168US12162881B2Forms and compositions of inhibitors of JAK2AJAX THERAPEUTICS INC·Filed 2022·Granted Dec 10, 2024·0 cites·20 claims
- 1265US2024368157A1Forms and compositions of a jak2 inhibitorAJAX THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1359US2024116892A1Heterocyclic amide and urea compounds as jak2 inhibitorsAJAX THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1456US2024158412A1Ubiquitin-specific protease 7 (usp7) inhibitors and uses thereofFAXIAN THERAPEUTICS LLC·Filed 2022·Application pending·0 cites
- 1546US9708308B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jul 18, 2017·0 cites·16 claims
- 1645US7790895B2Quinoline derivatives as potassium ion channel openersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Sep 7, 2010·0 cites·7 claims
- 1744US7671065B2Pyridine derivatives as potassium ion channel openersJANSSEN PHARMACEUTICA NV·Filed 2006·Granted Mar 2, 2010·0 cites·12 claims
- 1843US9453038B2Glucokinase activator compounds, compositions containing such compounds, and methods of treatmentMERCK SHARP & DOHME·Filed 2013·Granted Sep 27, 2016·0 cites·16 claims
- 1938US10214512B2Factor XIA inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·0 cites·14 claims
- 2036US10065945B2Isoquinoline derivatives as MGAT2 inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Sep 4, 2018·0 cites·14 claims
- 2136US9808445B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Nov 7, 2017·0 cites·19 claims
- 2236US2006166933A1Novel 2H-chromene derivatives as selective estrogen receptor modulatorsJAIN NARESHKUMAR F·Filed 2005·Application pending·0 cites
- 2335US10351558B2Factor IXa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jul 16, 2019·0 cites·11 claims
- 2430US9969724B2Factor IXa inhibitorsSAKURADA ISAO·Filed 2015·Granted May 15, 2018·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Jiayi Xu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →